With the recent merger with Physcian's Reliance, the former American Oncology(AORI) has changed its name to US Oncology(USON). This merger has IMO enhanced USON's growth prospects, as now approximately 1/3rd of all cancer patients in this country will receive medical treatment through USON doctors. USON is truly a growth company in what is regrettably a growing market. By limiting their management practice strictly to the oncology field, USON has avoided the problems encountered by many of the physician management firms. This success model is confirmed by the consistent revenue growth and profits achieved in the history of the company.
Let's talk about USON! |
